Pasta Maker Barilla Funds Cell Therapy Research For Coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to US non-profit association 'The Cure Alliance' to fund research on a COVID-19 therapy based on stem cells, the group has said.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the US Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous €2 million ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company's home country.